AstraZeneca

News

FDA clears J&J's 2-in-1 tablet for prostate cancer

Johnson & Johnson has been given FDA approval for Akeega, a combination tablet for first-line treatment of adults with BRCA-positive metastatic castration-resistant pr

Oncology

Heard on the pipeline: Technology in oncology

It’s not every day that experts from across the oncology field gather in one place to discuss the past, present, and future of cancer treatment.

Oncology

Healthcare is a team sport: Tackling cancer inequalities in ...

Throughout history, great scientific advancements have been made through collaboration.

News

AZ, Sanofi's Beyfortus gets CDC okay for RSV prevention

The final obstacle to the routine use of Sanofi and AstraZeneca's Beyfortus to prevent respiratory syncytial virus (RSV) in the US has fallen after it was backed by Centre

News

AZ and BMS resolve checkpoint inhibitor patent disputes

AstraZeneca has said that a trio of lawsuits filed by Bristol-Myers Squibb and Ono Pharma alleging patent infringement with its checkpoint inhibitor drugs Imjudo and Imfin

News

Jemperli cleared for frontline use in endometrial cancer

GSK has claimed US approval for Jemperli alongside chemotherapy for previously untreated, primary advanced or recurrent endometrial cancer, becoming the first immunotherap

FDA clears J&J's 2-in-1 tablet for prostate cancer

Heard on the pipeline: Technology in oncology

Healthcare is a team sport: Tackling cancer inequalities in ...

AZ, Sanofi's Beyfortus gets CDC okay for RSV prevention

AZ and BMS resolve checkpoint inhibitor patent disputes

Jemperli cleared for frontline use in endometrial cancer

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

AstraZeneca

Editor's Picks